Table 5.
Bacterial strains and antibiotics.
| Author | Bacteria | Type of antibiotics | Period of antibiotics |
|---|---|---|---|
| Anagnostakos et al.19 | S. marcescens, S. aureus | Flucloxacillin, clindamycin, levofloxacin, unknown administration path | Not described |
| Grecu et al.20 | Not described | Ceftriaxone 2 g/day | 10 days |
| Izadpanah et al.17 | MRSA, pseudomonas aeroguinosa, staphylococcus aureus, Enterococcus faecium, Bacillus species, staphylococcus epidermidis, streptococcus equisimilis, enterobacter cloacae, stentrophomonas maltoplillae, acinetobacter baumannii, VRE, Peptostreptococcus Species, Streptococcus agalagticae | cephalosporin or bacteria-specific | Not described |
| Kollrack et al.21 | S. aureus, Enterococcus | Not described | Not described |
| Marinovic et al.22 | Staphylococcus spp. | Azithromycin | Not described |
| Rawicki et al.26 | Staphylococcus aureus or Serratia marcescens | Zosyn and Rifampin or Ceftriaxone, via peripherally inserted central catheter | Not described |
| Roth et al.27 | Not described | 8 patients treated with systemic antibiotics if fever or generalized infection signs | Not described |
| Sharp et al.23 | Not described | Intra venous for one patient | Up to 6 weeks |
| Wijewardena et al.24 | Not described | None | None |
| Windhofer et al.25 | Staphylococcus aureus and epidermidis | 1. stage (Clindamycin and vancomycin), 2. stage (levofloxacin and doxycyclin) | Stage 1 for 4 weeks and stage 2 for 3 weeks |